Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Kiaxone 500mg Injection

Prescription Icon
Prescription Required

Marketer

Alicanto Drugs Pvt Ltd

Salt Composition

Ceftriaxone (500mg)

Overview Kiaxone 500mg Injection

Cephalosporin antibiotic Cefixime 500mg Injection combats various bacterial infections. Its applications encompass treating infections affecting the brain (meningitis), lungs (pneumonia), ears, urinary tract, skin and soft tissues, bones and joints, bloodstream, and heart. Prophylactically, it's used to prevent surgical site infections. Administered intravenously or intramuscularly by a healthcare professional, dosage is determined individually. Consistent, evenly spaced doses, as prescribed, are crucial; premature cessation can cause infection recurrence or exacerbation. Common side effects—diarrhea, rash, altered liver function tests, and abnormal blood cell counts (eosinophilia, leukopenia, thrombocytopenia)—are usually mild. Injection site reactions (redness, pain) may occur. Report persistent or bothersome side effects. Prior to treatment, disclose any antibiotic allergies, kidney or liver conditions, and all other medications being taken, as interactions are possible.

Uses of Kiaxone 500mg Injection

Combating Bacterial Infections

Major Benefits of Kiaxone 500mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Kiaxone 500mg Injection:

  • Diarrhea
  • Abnormal liver function tests
  • Rash
  • Increased white blood cell count (eosinophils)
  • Decreased white blood cell count
  • Low blood platelets

How to use Kiaxone 500mg Injection:

This medication will be administered by your healthcare provider; please do not attempt self-medication.

How Kiaxone 500mg Injection works:

Kiaxone 500mg injection is a bactericidal antibiotic. Its mechanism of action involves disrupting bacterial cell wall synthesis, rendering the bacteria unable to survive.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Kiaxone 500mg Injection and alcohol consumption.

PregnancyPregnancySAFE IF PRESCRIBED

Pregnancy use of Kiaxone 500mg Injection is considered safe. The majority of research indicates minimal or negligible fetal risk.

Breast feedingBreast feedingCAUTION

The administration of Kiaxone 500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.

DrivingDrivingUNSAFE

Administering Kiaxone 500mg Injection might reduce attentiveness, impair vision, or induce drowsiness and dizziness. Driving is prohibited should these effects manifest.

KidneyKidneySAFE IF PRESCRIBED

Kiaxone 500mg injections are suitable for patients with kidney conditions; no dosage modification is typically needed. Nevertheless, disclosure of any pre-existing kidney disease to your physician is advised.

LiverLiverCAUTION

Individuals with severe hepatic impairment should use Kiaxone 500mg Injection cautiously, potentially requiring dosage modification. Medical advice is recommended. Dosage alteration for Kiaxone 500mg Injection is unnecessary in those with mild or moderate liver dysfunction.

What if you forget to take Kiaxone 500mg Injection :

Should you forget a scheduled Kiaxone 500mg Injection, seek medical advice.

Facts to Know About Kiaxone 500mg Injection

LabelValue
Type of Compound Extended-coverage cephalosporins (including third- and fourth-generation agents)
Addictive None.
Medication Classification Antimicrobial agents

FAQs on Kiaxone 500mg Injection

Administering Kiaxone 500mg Injection is safe when used according to your physician's prescribed dosage and schedule. Strictly adhere to the recommended regimen and avoid missed injections. Closely observe your doctor's guidance and report any concerning adverse reactions.
The onset of action for a 500mg Kiaxone injection is typically rapid. Complete bacterial eradication and symptom resolution, however, might require several days.
Individuals with a known allergy to Kiaxone 500mg Injection or its components should not receive this medication. Prior liver, kidney, or gallbladder issues, or any history of blood disorders like hemolytic anemia, must be disclosed to your physician before administration. Pregnant or breastfeeding individuals, or those intending to conceive, should seek medical advice before using Kiaxone 500mg Injection to mitigate potential risks to the infant. Complete disclosure of all other medications currently being taken is crucial, as interactions with Kiaxone 500mg Injection are possible.
Contact your physician if your condition doesn't improve after completing the prescribed medication regimen. Report any worsening symptoms to your doctor while taking this medication.
The typical duration of Kiaxone 500mg Injection in the system following cessation is approximately 48 hours.
Administering Kiaxone 500mg Injection as directed by your physician ensures optimal efficacy. Continued use, as prescribed, is crucial, even with noticeable symptom improvement. Premature discontinuation of Kiaxone 500mg Injection may lead to symptom recurrence or exacerbation.
Administering Kiaxone 500mg Injection requires the guidance of a qualified medical practitioner; self-injection is strictly prohibited. Dosage is determined by your physician based on your specific medical needs. To optimize treatment outcomes, adhere precisely to your doctor's prescribed regimen for Kiaxone 500mg Injection.
Kiaxone 500mg Injection
29
MRP 34
14% off